Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Evaluation of NovoRapid infusion as a treatment option in the management of diabetic ketoacidosis

Kwok R, Sztal-Mazer S, Hopkins RE, Poole SG, Grannell L, Coutsouvelis J, Topliss DJ

(2017), Intern Med J, 47(11), 1317-20

DOI: 10.1111/imj.13607

Canagliflozin and cardiovascular and renal events in type 2 diabetes

Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group

(2017), N Engl J Med, 377(7), 644-57

DOI: 10.1056/NEJMoa1611925

Pancreatic safety of sitagliptin in the TECOS study

Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group

(2017), Diabetes Care, 40(2), 164-70

DOI: 10.2337/dc15-2780

The management of metastatic radioiodine-refractory differentiated thyroid cancer requires an integrated approach including both directed and systemic therapies

Cooray SD, Topliss DJ

(2017), Endocrinol Diabetes Metab Case Rep, 2017, 16-0089

DOI: 10.1530/EDM-16-0089

Set7 mediated interactions regulate transcriptional networks in embryonic stem cells

Tuano NK, Okabe J, Ziemann M, Cooper ME, El-Osta A

(2016), Nucleic Acids Res, 44(19)

Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study

Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Hendrieckx C, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Speight J, Trawley S, Ward GM, Roy A, Jones TW, O'N

(2016), Diabetes Technol Ther, 18(12)

Current ideas on the biology of IGFBP-6: more than an IGF-II inhibitor?

Bach LA

(2016), Growth Horm IGF Res, 30-31

Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products

McRobert EA, Bach LA

(2016), Nephrology, 21(1)

Clinical update in aspects of the management of autoimmune thyroid diseases

Topliss DJ

(2016), Endocrinol Metab, 31(4)

Immunoglobulin G4-related thyroid diseases

Kottahachchi D, Topliss DJ

(2016), Eur Thyroid J, 5(4)

Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study

Essig GF Jr, Porter K, Schneider D, Arpaia D, Lindsey SC, Busonero G, Fineberg D, Fruci B, Boelaert K, Smit JW, Meijer JA, Duntas LH, Sharma N, Costante G, Filetti S, Sippel RS, Biondi B, Topliss DJ, Pacini F, Maciel RM, Walz PC, Kloos RT

(2016), Thyroid, 26(11)

Lessons from the bedside: ketoacidosis and SGLT2 inhibitors

Chow YY, Worsley R, Topliss DJ

(2016), Med J Aust, 205(4)

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group

(2016), Diabetes Obes Metab, 18(1)

Hashimoto’s thyroiditis: when to observe, to treat or to refer

Kottahachchi D, Topliss DJ

(2016), Endocrinol Today, 5(2)

Use of anticoagulation in thyroid disease

Polmear JL, Hare MJ, Catford SR, Topliss DJ, Dooley MJ

(2016), Aust Fam Physician, 45(3)

Multi-trauma secondary to hypocalcaemia-induced seizure: A case report

Shenouda R, Carter S, Wang K, Chow Y, Topliss DJ, Esser MP

(2016), Trauma Case Rep, 6

Persistent syndrome of inappropriate antidiuretic hormone secretion following traumatic brain injury

Dick M, Catford SR, Kumareswaran K, Hamblin PS, Topliss DJ

(2015), Endocrinol Diabetes Metab Case Rep, 2015, 150070

Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group

(2015), N Engl J Med, 373(3), 232-42

A phase II trial of lenvatinib (E7080) in advanced progressive radioiodine-refractory differentiated thyroid cancer: a clinical outcomes and biomarker assessment

Cabanillas ME, Schlumberger M, Jarzab B, Martins RG, Pacini F, Robinson B, McCaffrey JC, Shah MH, Bodenner DL, Topliss D, Andresen C, O'Brien JP, Ren M, Funahashi Y, Allison R, Elisei R, Newbold K, Licitra LF, Sherman SI, Ball DW

(2015), Cancer, 121(16), 2749-56

Management guidelines for non-AIDS morbidity result in increased screening but no change in primary prevention

Trevillyan JM, Dart A, Topliss DJ, Walker RG, Whiting SE, Hoy JF

(2015), AIDS, 29(6), 748-50

4 5 6 7 8